162 related articles for article (PubMed ID: 31808782)
1. Determining the pathogenicity of CFTR missense variants: Multiple comparisons of in silico predictors and variant annotation databases.
Michels M; Matte U; Fraga LR; Mancuso ACB; Ligabue-Braun R; Berneira EFR; Siebert M; Sanseverino MTV
Genet Mol Biol; 2019; 42(3):560-570. PubMed ID: 31808782
[TBL] [Abstract][Full Text] [Related]
2. Benchmarking AlphaMissense pathogenicity predictions against cystic fibrosis variants.
McDonald EF; Oliver KE; Schlebach JP; Meiler J; Plate L
PLoS One; 2024; 19(1):e0297560. PubMed ID: 38271453
[TBL] [Abstract][Full Text] [Related]
3. Benchmarking AlphaMissense Pathogenicity Predictions Against Cystic Fibrosis Variants.
McDonald EF; Oliver KE; Schlebach JP; Meiler J; Plate L
bioRxiv; 2024 Jan; ():. PubMed ID: 37873426
[TBL] [Abstract][Full Text] [Related]
4. Functional Assays Are Essential for Interpretation of Missense Variants Associated with Variable Expressivity.
Raraigh KS; Han ST; Davis E; Evans TA; Pellicore MJ; McCague AF; Joynt AT; Lu Z; Atalar M; Sharma N; Sheridan MB; Sosnay PR; Cutting GR
Am J Hum Genet; 2018 Jun; 102(6):1062-1077. PubMed ID: 29805046
[TBL] [Abstract][Full Text] [Related]
5. A Novel Pathogenic Variant of the
Arslan AB; Zamani AG; Pekcan S; Yıldırım MS
J Pediatr Genet; 2020 Mar; 9(1):40-43. PubMed ID: 31976142
[TBL] [Abstract][Full Text] [Related]
6. The CYSMA web server: An example of integrative tool for in silico analysis of missense variants identified in Mendelian disorders.
Sasorith S; Baux D; Bergougnoux A; Paulet D; Lahure A; Bareil C; Taulan-Cadars M; Roux AF; Koenig M; Claustres M; Raynal C
Hum Mutat; 2020 Feb; 41(2):375-386. PubMed ID: 31674704
[TBL] [Abstract][Full Text] [Related]
7. CFTR-France, a national relational patient database for sharing genetic and phenotypic data associated with rare CFTR variants.
Claustres M; Thèze C; des Georges M; Baux D; Girodon E; Bienvenu T; Audrezet MP; Dugueperoux I; Férec C; Lalau G; Pagin A; Kitzis A; Thoreau V; Gaston V; Bieth E; Malinge MC; Reboul MP; Fergelot P; Lemonnier L; Mekki C; Fanen P; Bergougnoux A; Sasorith S; Raynal C; Bareil C
Hum Mutat; 2017 Oct; 38(10):1297-1315. PubMed ID: 28603918
[TBL] [Abstract][Full Text] [Related]
8. Pitfalls in the interpretation of CFTR variants in the context of incidental findings.
Boussaroque A; Bergougnoux A; Raynal C; Audrézet MP; Sasorith S; Férec C; Bienvenu T; Girodon E
Hum Mutat; 2019 Dec; 40(12):2239-2246. PubMed ID: 31350925
[TBL] [Abstract][Full Text] [Related]
9. Applying Cystic Fibrosis Transmembrane Conductance Regulator Genetics and CFTR2 Data to Facilitate Diagnoses.
Sosnay PR; Salinas DB; White TB; Ren CL; Farrell PM; Raraigh KS; Girodon E; Castellani C
J Pediatr; 2017 Feb; 181S():S27-S32.e1. PubMed ID: 28129809
[TBL] [Abstract][Full Text] [Related]
10. Frequency of Cystic Fibrosis Transmembrane Conductance Regulator Variants in Individuals Evaluated for Primary Ciliary Dyskinesia.
Hannah WB; Truty R; Gonzales V; Kithcart GP; Ouyang K; Zeman MK; Li C; Drumm M; Nykamp K; Gaston BM
J Pediatr; 2019 Dec; 215():172-177.e2. PubMed ID: 31610925
[TBL] [Abstract][Full Text] [Related]
11. Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene?
Dorfman R; Nalpathamkalam T; Taylor C; Gonska T; Keenan K; Yuan XW; Corey M; Tsui LC; Zielenski J; Durie P
Clin Genet; 2010 May; 77(5):464-73. PubMed ID: 20059485
[TBL] [Abstract][Full Text] [Related]
12. Transformative therapies for rare CFTR missense alleles.
Oliver KE; Han ST; Sorscher EJ; Cutting GR
Curr Opin Pharmacol; 2017 Jun; 34():76-82. PubMed ID: 29032041
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of CFTR gene sequence variants in a northern Portugal population.
Grangeia A; Alves S; Gonçalves L; Gregório I; Santos AC; Barros H; Barros A; Carvalho F; Moura C
Pulmonology; 2018; 24(1):3-9. PubMed ID: 29589582
[TBL] [Abstract][Full Text] [Related]
14. Novel gene-specific Bayesian Gaussian mixture model to predict the missense variants pathogenicity of Sanfilippo syndrome.
Mohammed EEA; Fayez AG; Abdelfattah NM; Fateen E
Sci Rep; 2024 May; 14(1):12148. PubMed ID: 38802532
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the predictive accuracy of five in silico prediction tools, alone or in combination, and two metaservers to classify long QT syndrome gene mutations.
Leong IU; Stuckey A; Lai D; Skinner JR; Love DR
BMC Med Genet; 2015 May; 16():34. PubMed ID: 25967940
[TBL] [Abstract][Full Text] [Related]
16. Residual function of cystic fibrosis mutants predicts response to small molecule CFTR modulators.
Han ST; Rab A; Pellicore MJ; Davis EF; McCague AF; Evans TA; Joynt AT; Lu Z; Cai Z; Raraigh KS; Hong JS; Sheppard DN; Sorscher EJ; Cutting GR
JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046002
[TBL] [Abstract][Full Text] [Related]
17. Analysis of AlphaMissense data in different protein groups and structural context.
Tordai H; Torres O; Csepi M; Padányi R; Lukács GL; Hegedűs T
Sci Data; 2024 May; 11(1):495. PubMed ID: 38744964
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation.
Farrell PM; White TB; Ren CL; Hempstead SE; Accurso F; Derichs N; Howenstine M; McColley SA; Rock M; Rosenfeld M; Sermet-Gaudelus I; Southern KW; Marshall BC; Sosnay PR
J Pediatr; 2017 Feb; 181S():S4-S15.e1. PubMed ID: 28129811
[TBL] [Abstract][Full Text] [Related]
19. Validation of CFTR intronic variants identified during cystic fibrosis population screening by a minigene splicing assay.
Giorgi G; Casarin A; Trevisson E; Donà M; Cassina M; Graziano C; Picci L; Clementi M; Salviati L
Clin Chem Lab Med; 2015 Oct; 53(11):1719-23. PubMed ID: 25781545
[TBL] [Abstract][Full Text] [Related]
20. N-terminal CFTR missense variants severely affect the behavior of the CFTR chloride channel.
Gené GG; Llobet A; Larriba S; de Semir D; Martínez I; Escalada A; Solsona C; Casals T; Aran JM
Hum Mutat; 2008 May; 29(5):738-49. PubMed ID: 18306312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
